Belgian Group of Digestive Oncology

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
Testing Ivonescimab Versus FOLFOX in Advanced Biliary Tract Cancer Patients	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, biliary tract cancer, biliary tract disorder, carcinoma, cholangiocarcinoma, epithelial neoplasm, neoplasm	Recruiting	Phase 2	2026-08-28	NCT06529718
Personalized Medicine for Advanced Biliary Cancer Patients	Biliary Tract Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, biliary tract disorder, neoplasm	Recruiting	Phase 3	2026-05-19	NCT05615818
A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC (NALPAC)	Metastatic Pancreatic Ductal Adenocarcinoma	Recruiting	Phase 2	2025-02-06	NCT05472259
Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma	Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, endocrine system disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic adenocarcinoma, pancreatic neoplasm	Recruiting	Phase 2	2023-05-23	NCT05083247

Clinical trials